Can We Reduce Morbidity & Mortality In Viper Snake Bite?
Keywords:
Immunotherapy, Antivenin, Haemogram, Serial evaluation, TrendsAbstract
Objective: The objective of the study was to reduce the mortality and morbidity in viper snake bites by optimizing antivenin dose with clinical signs and laboratory value trends. Methodology: In this Retrospective study. Retrospective analysis was done in 23 severely envenomed cases to find out the various percentages of morbidity and mortality. In year 2011 immunotherapy was optimized by estimation of haemogram for trends of WBC and platelets, this resulted into reduction in the morbidity and mortality. In year 2012-2013, initial dose of antivenin was correlated clinically with epigastric tenderness and additional doses were modified using above laboratory value trends. Total 28 viper snake bite cases were treated and the morbidity and mortality was reduced substantially by using the modified protocol. Result: Improved outcomes correlate well with laboratory trends causing decrease in mortality and morbidity in viper snake bite. Conclusion: If we modify the dose schedule of immunotherapy using clinical signs and value trends as guidelines, morbidity and mortality in viper snake bite can be reduced substantially, reducing hospital stay, use of blood products and the cost.
Downloads
References
Adam Garkowski, Pitor Czupryna, Agatha Zajkowska, Slawomir Pancewicz, Anna Mouniuszko, Maciej Kondrusik, Sambor Grygorczuk, Pawel Golebic, Michal Letmanowski; Viper aberus bites in Eastern Poland – A retrospective analysis of 15 case studies. Annals of agricultural and environmental medicine 2012 vol. 19 no 4, 793-797.
Avinash Agarwal, Alok Gupta, and Arun Khanna; What dose of anti-snake venom should be given in severe neuroparalytic snake bite. Human Exp Toxicol 1994 oct 13(10) 683-8.
Audebert F. Sorkine, M. Robbe-Vincent, A. Bon C.; Viper bites in Frence; clinical and biological evaluation; kinetics of envenomations. Human Exp Toxicol 1994 oct 13(10) 683-8.
J. Srimannarayana, T.K. Dutta,A. Sahai, S. Badrinath, Rational use of ASV; Trial of various regimens in haemostatic snake envenomation. JAPI vol 52 oct. 2004.
D. P. Punde; Snake Bite (prespective of elapidae bites in rural Maharashtra) First Edition.
Gilles Riviere Valerie Choument, Francoise Audebert, Alain Sabouraud, Marcel Debray, Jean Michel Scherrmann, and Cassian Bon; Effect of antivenom on venom pharmacokinetics in experimentally envenomed rabbits; towards optimization of antivenom therapy. The journal of Pharmacology and Experimental Theraputics JPET 280;1-8-1997.
G. K. Isbister, K. Madhuwage, S. Shamy, F. Mohamed, C. Abet Singhe, H. Karunathilake, C. A. Ariaratnam, and N. A. Buckley, diagnostic 20-min whole blood clotting test in Russel’s viper envenoming delays antivenom administration. QJM May 14, 2013.
Coagulopathy in patient who experience snakebite. Korean J. Intern Med 2008, June 23(2) 94-99.
Nasser A. Haider, Muhammad Y. Emran, Eman A. AI Muslemani, Snakebits in Hajjah. Yemen Republic; Epidemiology management and relation of degrees of actuity at presentation with outcome. Journal of emergency medicine, trauma and acute care 2012;2.
Jaques Pettie, Viper bites; treat or ignore? Swiss med wkly 2005;618-625.
Dhanya S.P.Bindu Latta R, Dhanya T. H. Antisnakevenom use; A retrospective analysis in a tertiary care centre. Calicut Medical Journal 20097(3).
V. Paul, S. Pratibha, K. A. Pralhad, Jerry Erali, S. Francis, Francy lewis, High dose ASV versus Low dose ASV in treatment of poisonous snakebites. A critical study. JAPI vol52-January 2004.
R. D. G. Theakston, A. S. Kamiguti, viper envenoming, evalution of treatment by restoration of haemostasis and venom clearance, J. Venom Anim Toxins Vol4 n 2 botucatu 1998.
Vinodkumar , toxicity and symptomatic identification of species involved in snakebites in the indian subcontinent. J. Venom Anim. Toxins, incl. Dis. V. 12, n, 1.3-18 2008.
Rodney E. Philips, Tun-pe, David A. Warrel, Tin- Nu-Swe, Maung-Lay; bites by russels viper (vipera russellisi amensis) in Burma Haemostatic, vascular, and renal disturbances and response to treatment. The lancet, vol. 326 issue 8467 pg.1259-1264 Dec. 1985
Published
How to Cite
Issue
Section
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
